Vaishali Pharma Ltd.
Snapshot View

126.50 -0.85 ▼-0.7%

09 February 2023, 03:23:52 PM
Volume: 105,219

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vaishalipharma.com
Market Cap 133.83 Cr.
Enterprise Value(EV) 152.31 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 6.04 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 21.00 Trailing Twelve Months Ending 2022-12
Industry PE 30.86 Trailing Twelve Months Ending 2022-12
Book Value / Share 30.84 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.12 Calculated using Price: 126.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.05 Cr. 10,546,213 Shares
FaceValue 10
Company Profile
The company is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For its export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, it has applied for 186 registrations in 13 countries for some of its products, out of which it has successfully received 71 approvals from 7 countries and is in process of obtaining remaining approvals, which will give boost to its export business operations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.67%
1 Week
-6.88%
1 Month
-15.75%
3 Month
+23.90%
6 Month
+42.54%
1 Year
+214.68%
2 Year
+213.51%
5 Year
+205.48%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.28 5.12 -0.94 19.80 6.49 3.40 0.15 4.78 16.50
Return on Capital Employed (%) 19.23 14.04 12.80 16.18 12.75 9.80 6.89 10.33 18.87
Return on Assets (%) 0.59 0.33 -0.06 1.51 1.47 1.08 0.05 1.38 4.81

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3 3 3 4 21 21 21 22 26 30
Non Curr. Liab. 3 8 5 3 3 5 4 4 3 4
Curr. Liab. 47 34 42 37 41 42 40 59 52 41
Minority Int.
Equity & Liab. 53 46 49 45 64 69 66 86 81 75
Non Curr. Assets 2 2 2 5 5 6 5 5 5 6
Curr. Assets 52 44 47 40 59 63 61 81 76 69
Misc. Exp. not W/O
Total Assets 53 46 49 45 64 69 66 86 81 75

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 121 95 67 64 68 75 60 54 76 69
Other Income 1 4 3 1 2 2 2 2 2 2
Total Income 122 99 70 65 69 77 62 56 78 71
Total Expenditure -118 -95 -66 -61 -65 -73 -59 -51 -69 -60
PBIDT 3 4 4 4 4 4 3 4 9 11
Interest -3 -3 -3 -3 -3 -3 -3 -3 -2 -2
Depreciation 0 0 0 0 0 0 0 0 0 -1
Taxation 0 0 0 0 -1 0 0 0 -2 -2
Exceptional Items
PAT 0 0 0 1 1 1 0 1 4 6
Adjusted EPS 4 2 0 1 1 1 0 1 4 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 -7 -4 5 0 -9 4 3 2 1
Cash Fr. Inv. 0 0 2 3 1 1 0 0 0 -1
Cash Fr. Finan. -4 6 2 -8 -1 9 -4 -3 -2 0
Net Change 0 -1 0 0 0 0 0 0 1
Cash & Cash Eqvt 2 1 1 1 0 0 0 0 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 63.84 63.81 59.21 56.31 56.31 26.74 26.74 26.74 26.74
Public 36.16 36.19 40.80 43.69 43.69 73.25 73.26 73.26 73.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 08 Feb 2023
Outcome of Board Meeting
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on February 07, 2023.
Wed, 08 Feb 2023
Outcome of Board Meeting
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on February 07, 2023.
Tue, 07 Feb 2023
Financial Result Updates
Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.

Technical Scans View Details >>

Wed, 08 Feb 2023
Closing Below Previous Low Closing Below Previous Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.25 -0.7%
Cipla Ltd. 83,886.47 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,484.70 -0.1%
Divi's Laboratories Ltd. 74,340.49 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. 52,675.65 1,539.10 -1.1%
Zydus Lifesciences Ltd. 47,993.66 474.35 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-12 31.80 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,484.70 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.35 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-12 3.70 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,484.70 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.35 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,484.70 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.35 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,484.70 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.35 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,484.70 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.35 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,484.70 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.35 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.25 -0.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,021.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,484.70 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.85 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,384.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,539.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.35 +0.1%

FAQ's On Vaishali Pharma Ltd.

What is Vaishali Pharma share price?

Can I buy Vaishali Pharma shares now?

What is the Market Cap of Vaishali Pharma?

What are the key metrics to analyse Vaishali Pharma?

What is the 52 Week High and Low of Vaishali Pharma?

What is the trend of Vaishali Pharma share price?